Alternative approaches to target Myc for cancer treatment
The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL,
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …
Target gene-independent functions of MYC oncoproteins
Oncoproteins of the MYC family are major drivers of human tumorigenesis. Since a large
body of evidence indicates that MYC proteins are transcription factors, studying their function …
body of evidence indicates that MYC proteins are transcription factors, studying their function …
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
C Dubiella, BJ Pinch, K Koikawa, D Zaidman… - Nature chemical …, 2021 - nature.com
The peptidyl-prolyl isomerase, Pin1, is exploited in cancer to activate oncogenes and
inactivate tumor suppressors. However, despite considerable efforts, Pin1 has remained an …
inactivate tumor suppressors. However, despite considerable efforts, Pin1 has remained an …
Mission possible: advances in MYC therapeutic targeting in cancer
BL Allen-Petersen, RC Sears - BioDrugs, 2019 - Springer
MYC is a master transcriptional regulator that controls almost all cellular processes. Over the
last several decades, researchers have strived to define the context-dependent …
last several decades, researchers have strived to define the context-dependent …
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
c-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCFFbw7
ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron …
ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron …
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153
Bone mass is maintained by the balance between osteoclast-induced bone resorption and
osteoblast-triggered bone formation. In inflammatory arthritis such as rheumatoid arthritis …
osteoblast-triggered bone formation. In inflammatory arthritis such as rheumatoid arthritis …
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
MYC-driven medulloblastomas are highly aggressive childhood brain tumors, however, the
molecular and genetic events triggering MYC amplification and malignant transformation …
molecular and genetic events triggering MYC amplification and malignant transformation …
Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding
S Kadota, J Ou, Y Shi, JT Lee, J Sun… - Nature …, 2020 - nature.com
Nucleoporin proteins (Nups) have been proposed to mediate spatial and temporal
chromatin organization during gene regulation. Nevertheless, the molecular mechanisms in …
chromatin organization during gene regulation. Nevertheless, the molecular mechanisms in …
Therapeutic targets for endothelial dysfunction in vascular diseases
Vascular endothelial cells are located on the surface of the blood vessels. It has been
recognized as an important barrier to the regulation of vascular homeostasis by regulating …
recognized as an important barrier to the regulation of vascular homeostasis by regulating …
WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating
BA Scholz, N Sumida, CDM de Lima, I Chachoua… - Nature …, 2019 - nature.com
WNT signaling activates MYC expression in cancer cells. Here we report that this involves
an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to …
an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to …